Atrium Therapeutics shares owned by Cannon Global Investment Management
Quarter-by-quarter ownership of Atrium Therapeutics (RNA) shares owned by Cannon Global Investment Management
from 13F filings
Historical chart of Cannon Global Investment Management investment in Atrium Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Atrium Therapeutics held by Cannon Global Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Atrium Therapeutics by Cannon Global Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $335k | 25k | 13.37 |
More positions owned by Cannon Global Investment Management
View all positions for Cannon Global Investment Management